These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37405474)

  • 1. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
    Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
    Wang SC; Wu CH; Fu HC; Ou YC; Tsai CC; Chen YY; Wang YW; Hunag SW; Huang SY; Lan J; Lin H
    Int J Gynecol Pathol; 2024 Jul; 43(4):316-325. PubMed ID: 37732995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.
    Hsiao YY; Fu HC; Wu CH; Lan J; Ou YC; Tsai CC; Lin H
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of pretreatment tumor markers in a nomogram model for prognostic prediction of FIGO stage I endometrial cancer: A multi-institutional cohort study.
    Lin H; Wu CH; Ou YC; Huang SW; Fu HC
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1244-1256. PubMed ID: 38287783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma.
    Guo X; Lin C; Zhao J; Tang M
    BMC Cancer; 2022 Dec; 22(1):1333. PubMed ID: 36539714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
    Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
    Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
    Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
    Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis.
    Wang K; Jiang X; Ren Y; Ma Z; Cheng X; Li F; Xiao J; Yu Z; Jiao Z
    BMC Gastroenterol; 2020 Apr; 20(1):100. PubMed ID: 32276616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.
    Zhao LY; Yin Y; Li X; Zhu CJ; Wang YG; Chen XL; Zhang WH; Chen XZ; Yang K; Liu K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Oncotarget; 2016 Sep; 7(37):59630-59639. PubMed ID: 27449100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram prediction model for lymph node metastasis in endometrial cancer patients.
    Wang Z; Zhang S; Ma Y; Li W; Tian J; Liu T
    BMC Cancer; 2021 Jun; 21(1):748. PubMed ID: 34187416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for pelvic lymph node metastasis in endometrial cancer.
    Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
    Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
    Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
    Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
    Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
    Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.
    Feng X; Li XC; Yang X; Cheng Y; Dong YY; Wang JY; Zhou JY; Wang JL
    BMC Cancer; 2023 Jul; 23(1):622. PubMed ID: 37403054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
    Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
    Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.